Complement inhibition in severe COVID-19 – Blocking C5a seems to be key

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f82422573ce442ecb06abe29b7ce8272,

title = "Complement inhibition in severe COVID-19 – Blocking C5a seems to be key",

author = "Lim, \{Endry H. T.\} and Vlaar, \{Alexander P. J.\} and Sanne de-Bruin and Brouwer, \{Matthijs C.\} and Diederik van-de-Beek",

year = "2021",

month = may,

day = "1",

doi = "10.1016/j.eclinm.2021.100722",

language = "English",

volume = "35",

journal = "EClinicalMedicine",

publisher = "Lancet Publishing Group",

}

TY - JOUR

T1 - Complement inhibition in severe COVID-19 – Blocking C5a seems to be key

AU - Lim, Endry H. T.

AU - Vlaar, Alexander P. J.

AU - de-Bruin, Sanne

AU - Brouwer, Matthijs C.

AU - van-de-Beek, Diederik

PY - 2021/5/1

Y1 - 2021/5/1

UR - https://www.scopus.com/pages/publications/85105592603

U2 - 10.1016/j.eclinm.2021.100722

DO - 10.1016/j.eclinm.2021.100722

M3 - Comment/Letter to the editor

C2 - 33997737

VL - 35

JO - EClinicalMedicine

JF - EClinicalMedicine

M1 - 100722

ER -